SARS-CoV-2 alpha variant: is it really more deadly? A population-level observational study.
Moore, C. M.; Sergienko, R.; Arbel, R.
Show abstract
BackgroundIn 2021 a new variant of SARS-CoV-2, which came to be called the alpha variant, spread around the world. There were conflicting reports on this COVID-19 variant strains potentially increased lethality. In Israel, this strain became predominant in a very short time period. MethodsCOVID-19 mortality and case fatality rates were examined in Israel in terms of weekly and cumulative numbers. ResultsCOVID-19 case fatality rates in Israel rose quickly at the beginning of the pandemic and peaked in May 2020. The highest crude mortality came later in the second and third waves, but case the case fatality rates did not rise in 2021 with the increasing dominance of the alpha variant. ConclusionsBased on the results of examining case-fatality and mortality rates, we concluded that while the alpha variant of the virus raised mortality, in line with the fact that it is more infectious than wild-type, once this strain was caught by patients in Israel, it was not more likely to kill them than the original strain
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children 92%
- Passage of human-origin influenza A virus in swine tracheal epithelial cells selects for adaptive mutations in the hemagglutinin gene 92%
- Molecular epidemiology of mumps viruses detected in the Netherlands, 2017-2019 92%
Similar papers in this journal
- Genomic characterization of respiratory syncytial virus 2022-2023 outbreak in Washington State, USA 93%
- Novel incursion of a highly pathogenic avian influenza subtype H5N8 virus in the Netherlands, October 2020 93%
- Novel Hendra virus variant detected by sentinel surveillance of Australian horses. 92%
Similar papers in this journal
- Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant 93%
- An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India 93%
- Breakthrough infection with SARS-CoV-2 and its predictors among healthcare workers in a medical college and hospital complex in Delhi, India 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.